Cogent Biosciences Inc (NASDAQ:COGT) currently has a daily average trading volume of 2.65M but it saw 3677326 shares traded in last market. With a market cap of 2.00B USD, the company’s current market price of $12.2 came rising about 2.87 while comparing to the previous closing price of $11.86. In past 52 weeks, the stock remained buoying in the range of price level as high as $12.61 and as low as $3.72. In the recent trading on the day, stock has struck highest price mark of $11.7901 while lowest mark touched by it was $12.515.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Scotiabank which initiated the stock as “Sector Outperform” in its note to investors issued on March 07, 2025, recommending a price target of $17 for it. Robert W. Baird issued its recommendations for the stock as it downgraded the price target for the stock in the range of between $14 and $8.
Over the week, COGT’s stock price is moving 12.44% up while it is 62.88% when we observe its performance for the past one month. Year-to-date it is 31.89% up and over the past year, the stock is showing an upside performance of 56.41%.
Currently, Cogent Biosciences Inc’s total number of outstanding shares is 163.81M. Company’s return on investment (ROI) stands at -109.60% and return on equity (ROE) at -84.04%. Stock’s beta reads 0.30. Stock has a price to book (P/B) ratio of 12.53. Its return on asset (ROA) is -70.93% on average.
